According to a March 19 news release, the Tiger Tech COVID Plus Monitor will identify certain biomarkers that can be indicative of COVID-19 by using light sensors and a computer processor in an armband.
The sensor obtains pulsatile signals from blood flow, then extracts key features from those signals to make predictions on whether someone is showing signals common in COVID-19 patients, such as hypercoagulation in the blood.
The screening tool can be used in asymptomatic patients above the age of 5. It is not a COVID-19 diagnostic device and cannot be used on individuals with a fever.
More articles on artificial intelligence:
Machine learning tool can predict severe illness, death from COVID-19 in patients
AI could replicate, compound existing disparities in COVID-19 care, study finds
AI tool uses EHR data mining to support diagnostic decision-making